These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1240099)

  • 1. Ascorbate 2-sulfate inhibits dopamine beta-hydroxylase reaction, but not ascorbate oxidase reaction.
    Hatanaka H; Egami F; Kato T; Nagatsu T
    J Biochem; 1975 Oct; 78(4):821-4. PubMed ID: 1240099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct spectrophotometric detection of ascorbate free radical formed by dopamine beta-monooxygenase and by ascorbate oxidase.
    Skotland T; Ljones T
    Biochim Biophys Acta; 1980 Jun; 630(1):30-5. PubMed ID: 7388045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of dopamine beta-monooxygenase by hydrogen peroxide and by ascorbate.
    Skotland T; Ljones T
    Arch Biochem Biophys; 1980 Apr; 201(1):81-7. PubMed ID: 7396512
    [No Abstract]   [Full Text] [Related]  

  • 4. The in situ kinetics of dopamine beta-hydroxylase in bovine adrenomedullary chromaffin cells. Intravesicular compartmentation reduces apparent affinity for the cofactor ascorbate.
    Menniti FS; Knoth J; Peterson DS; Diliberto EJ
    J Biol Chem; 1987 Jun; 262(16):7651-7. PubMed ID: 3584135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification of dopamine-beta-monooxygenase and extremely acidic, copper-containing proteins from the adrenal medulla. Extremely acidic, copper-containing proteins as electron donors for dopamine-beta-monooxygenase].
    Boiadzhian AS
    Biokhimiia; 1985 Jan; 50(1):84-90. PubMed ID: 3978154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbate based novel high affinity alternate reductants and competitive inhibitors of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S; Wimalasena DS
    Biochem Biophys Res Commun; 1994 Apr; 200(1):113-9. PubMed ID: 8166679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dopamine beta-hydroxylase by 2-mercapto-1-methylimidazole.
    Rosenberg RC
    Biochim Biophys Acta; 1983 Dec; 749(3):276-80. PubMed ID: 6661441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
    Aunis D; Miras-Portugal MT; Mandel P
    Biochem Pharmacol; 1973 Oct; 22(20):2581-9. PubMed ID: 4763594
    [No Abstract]   [Full Text] [Related]  

  • 9. An acetylenic mechanism-based inhibitor of dopamine beta-hydroxylase.
    Colombo G; Villafranca JJ
    J Biol Chem; 1984 Dec; 259(24):15017-20. PubMed ID: 6511785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ascorbic acid in dopamine beta-hydroxylation. The endogenous enzyme cofactor and putative electron donor for cofactor regeneration.
    Menniti FS; Knoth J; Diliberto EJ
    J Biol Chem; 1986 Dec; 261(36):16901-8. PubMed ID: 3097015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence about the catecholoxidase activity of the enzyme ascorbate oxidase extracted from Cucurbita pepo medullosa.
    Marchesini A; Capelletti P; Canonica L; Danieli B; Tollari S
    Biochim Biophys Acta; 1977 Oct; 484(2):290-300. PubMed ID: 20960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaerobic reaction of ascorbate oxidase with ascorbate.
    Avigliano L; Rotilio G; Urbanelli S; Mondovi B; Agrò AF
    Arch Biochem Biophys; 1978 Jan; 185(2):419-22. PubMed ID: 626502
    [No Abstract]   [Full Text] [Related]  

  • 13. The reduction of membrane-bound dopamine beta-monooxygenase in resealed chromaffin granule ghosts. Is intragranular ascorbic acid a mediator for extragranular reducing equivalents?
    Wimalasena K; Wimalasena DS
    J Biol Chem; 1995 Nov; 270(46):27516-24. PubMed ID: 7499210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction of ascorbate oxidase with inorganic anions].
    Aikazian VTs; Nalbandian RM
    Biokhimiia; 1977 Nov; 42(11):2027-34. PubMed ID: 588636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase.
    Rosenberg RC; Lovenberg W
    Essays Neurochem Neuropharmacol; 1980; 4():163-209. PubMed ID: 6248338
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity of ascorbate oxidase.
    Dayan J; Dawson CR
    Biochem Biophys Res Commun; 1976 Nov; 73(2):451-8. PubMed ID: 11800
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of dopamine-beta-hydroxylase, A copper enzyme, by bleomycin.
    Matsui H; Kato T; Yamamoto C; Takita T; Takeuchi T; Umezawa H; Nagatsu T
    J Antibiot (Tokyo); 1980 Apr; 33(4):435-40. PubMed ID: 6157665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ascorbic acid transport by adrenomedullary chromaffin cells. Evidence for Na+-dependent co-transport.
    Diliberto EJ; Heckman GD; Daniels AJ
    J Biol Chem; 1983 Nov; 258(21):12886-94. PubMed ID: 6630211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity of ascorbate oxidase: unexpected similarity to the reduction site of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1471-6. PubMed ID: 7945293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.